4.6 Review

Targeting transcription factor NF-κB to overcome chemoresistance and radioresistance in cancer therapy

期刊

出版社

ELSEVIER SCIENCE BV
DOI: 10.1016/j.bbcan.2010.01.002

关键词

NF-kappa B; Cancer; Chemoresistance; Radioresistance; Apoptosis

资金

  1. Department of Research and Technology [R-184-000-157-133]

向作者/读者索取更多资源

Activation of transcription factor NF-kappa B is frequently encountered in tumor cells and contributes to aggressive tumor growth and resistance to chemotherapy and ionizing radiation during cancer treatment. Accumulating evidence over the last few years indicate that most chemotherapeutic agents and radiation therapy activate NF-kappa B in vitro and in vivo. Moreover, induction of chemoresistance and radioresistance is mediated through several genes regulated by NF-kappa B and inhibition of this transcription factor increases sensitivity of cancer cells to the apoptotic action of chemotherapeutic agents and to radiation exposure. This review explores the role of NF-kappa B and its regulated genes in resistance of tumor cells to chemotherapeutic agents and radiation and evaluates the importance of targeting NF-kappa B as a potential therapeutic approach to overcome chemoresistance and radioresistance for cancer treatment. (C) 2010 Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Biochemistry & Molecular Biology

Repurposing FDA-approved drugs as FXR agonists: a structure based in silico pharmacological study

Sandra Jose, Sreevidya S. Devi, Anjana Sajeev, Sosmitha Girisa, Mohammed S. Alqahtani, Mohamed Abbas, Abdulrahman Alshammari, Gautam Sethi, Ajaikumar B. Kunnumakkara

Summary: Farnesoid X receptor (FXR) regulates genes involved in lipid, carbohydrate, and inflammatory processes. It is a possible tumor suppressor and its down-regulation is associated with various diseases. FXR agonism has been shown to improve survival in certain cancers, and the development of novel agonists could have therapeutic potential. Computer-aided drug design can be used to identify potential candidates, and alvimopan and montelukast were found to have strong binding affinity with FXR in this study.

BIOSCIENCE REPORTS (2023)

Review Biotechnology & Applied Microbiology

(Nano)platforms in bladder cancer therapy: Challenges and opportunities

Milad Ashrafizadeh, Ali Zarrabi, Hassan Karimi-Maleh, Afshin Taheriazam, Sepideh Mirzaei, Mehrdad Hashemi, Kiavash Hushmandi, Pooyan Makvandi, Ehsan Nazarzadeh Zare, Esmaeel Sharifi, Arul Goel, Lingzhi Wang, Jun Ren, Yavuz Nuri Ertas, Alan Prem Kumar, Yuzhuo Wang, Navid Rabiee, Gautam Sethi, Zhaowu Ma

Summary: Nanomedicine has great potential in the treatment of bladder cancer, including improving drug efficacy, regulating gene expression, providing photodynamic and photothermal therapy, remodeling tumor microenvironment and infiltration of immune cells, timely diagnosis, and targeted therapy for bladder cancer.

BIOENGINEERING & TRANSLATIONAL MEDICINE (2023)

Correction Chemistry, Medicinal

The multifaceted role of STAT3 pathway and its implication as a potential therapeutic target in oral cancer [vol 45, pg 507, 2022]

Elina Khatoon, Mangala Hegde, Aviral Kumar, Uzini Devi Daimary, Gautam Sethi, Anupam Bishayee, Ajaikumar B. Kunnumakkara

ARCHIVES OF PHARMACAL RESEARCH (2023)

Article Oncology

Nanoparticles in the diagnosis and treatment of cancer metastases: Current and future perspectives

Mangala Hegde, Nikunj Naliyadhara, Jyothsna Unnikrishnan, Mohammed S. Alqahtani, Mohamed Abbas, Sosmitha Girisa, Gautam Sethi, Ajaikumar B. Kunnumakkara

Summary: Metastasis is the main cause of cancer-related deaths, and despite advancements in treatment methods, it remains difficult to treat. Nanotechnology has shown promising applications in the diagnosis and treatment of metastatic cancer, with nanoparticles demonstrating the ability to target specific cells within metastatic regions. This review summarizes the current state of nanotechnology in the field and discusses its potential in various imaging techniques and combination therapies.

CANCER LETTERS (2023)

Review Biochemistry & Molecular Biology

Exosomal noncoding RNA-mediated spatiotemporal regulation of lipid metabolism: Implications in immune evasion and chronic inflammation

Mangala Hegde, Aviral Kumar, Sosmitha Girisa, Mohammed S. Alqahtani, Mohamed Abbas, Akul Goel, Kam Man Hui, Gautam Sethi, Ajaikumar B. Kunnumakkara

Summary: The hallmark of chronic inflammatory diseases is immune evasion, and exosomes play a critical role in immunomodulation and lipid metabolism during the development and progression of these diseases.

CYTOKINE & GROWTH FACTOR REVIEWS (2023)

Review Cell Biology

Long noncoding RNAs induced control of ferroptosis: Implications in cancer progression and treatment

Wei Shi, Gautam Sethi

Summary: A novel form of cell death called ferroptosis, which is iron-dependent and nonapoptotic, is triggered by lipid peroxidation. The regulation of ferroptosis has been found to play a crucial role in various pathological processes, including cancer. Recent studies suggest that understanding and targeting ferroptosis may provide a potential therapeutic strategy for cancer management, especially in the context of resistance to standard chemoradiotherapy. Long noncoding RNAs (lncRNAs) have been implicated in tumorigenesis and have been identified as regulators of ferroptosis, presenting an exciting avenue for cancer therapy. However, further research is needed to fully understand the mechanisms and potential treatments involving lncRNAs in the context of ferroptosis.

JOURNAL OF CELLULAR PHYSIOLOGY (2023)

Review Chemistry, Medicinal

Noncoding RNAs as regulators of STAT3 pathway in gastrointestinal cancers: Roles in cancer progression and therapeutic response

Milad Ashrafizadeh, Chakrabhavi D. Mohan, Shobith Rangappa, Ali Zarrabi, Kiavash Hushmandi, Alan Prem Kumar, Gautam Sethi, Kanchugarakoppal S. Rangappa

Summary: Gastrointestinal (GI) tumors are a major cause of death worldwide. STAT3 is an oncogenic transcription factor that promotes tumor progression, metastasis, and drug resistance. Recent research has shown that noncoding RNAs (ncRNAs) play a major role in regulating the STAT3 pathway. This article discusses the role of STAT3 signaling in promoting GI tumors and comprehensively explores the oncogenic and tumor suppressor functions of ncRNAs that modulate STAT3 signaling in GI cancers.

MEDICINAL RESEARCH REVIEWS (2023)

Review Chemistry, Medicinal

Mechanism of epithelial-mesenchymal transition in cancer and its regulation by natural compounds

Hui Li Ang, Chakrabhavi Dhananjaya Mohan, Muthu K. Shanmugam, Hin Chong Leong, Pooyan Makvandi, Kanchugarakoppal S. Rangappa, Anupam Bishyaee, Alan Prem Kumar, Gautam Sethi

Summary: Epithelial-mesenchymal transition (EMT) is a crucial process in which epithelial cells transform into mesenchymal cells, playing a significant role in tumor progression and resistance to therapy. Various factors, such as signaling pathways, transcriptional regulators, noncoding RNAs, and epigenetic alterations, are involved in the regulation of EMT. However, despite preclinical data, there is a lack of clinical translation in targeting EMT therapeutically. This review discusses the role of these factors in EMT regulation, the contribution of EMT to drug resistance, and potential therapeutic interventions using natural products and nano-formulations as EMT blockers.

MEDICINAL RESEARCH REVIEWS (2023)

Article Chemistry, Medicinal

Mesenchymal stem cell-derived rapid drug screening system for Alzheimer's disease for the identification of novel drugs

Naisarg Gamit, Manasi Patil, Soumya B. Sundrappa, S. Mohana Sundaram, Gautam Sethi, Arun Dharmarajan, Sudha Warrier

Summary: A reliable and efficient in vitro model using amniotic membrane-derived mesenchymal stem cells (AM-MSCs) has been developed for screening drugs for Alzheimer's disease (AD). This model can assess the neuroprotective ability of different drugs and quickly test a large number of potential compounds. The study found that the novel drugs probucol and NMJ-2 have protective effects against neurodegeneration.

DRUG DEVELOPMENT RESEARCH (2023)

Article Chemistry, Medicinal

A new triazolyl-indolo-quinoxaline induces apoptosis in gastric cancer cells by abrogating the STAT3/5 pathway through upregulation of PTPeC

Rajaghatta N. Suresh, Young Y. Jung, Chakrabhavi D. Mohan, Shalini V. Gowda, Kachigere B. Harsha, Kempegowda Mantelingu, Gautam Sethi, Kwang S. Ahn, Kanchugarakoppal S. Rangappa

Summary: In this study, new compounds called DTI were synthesized and found to exhibit selective cytotoxicity against gastric cancer cells. The cytotoxic effect was achieved by inhibiting the phosphorylation of STAT3 and STAT5, which are transcription factors involved in cancer development. Further investigation revealed that the inhibition of STAT proteins was mediated through the suppression of upstream kinases such as JAK1, JAK2, and Src. The involvement of tyrosine phosphatase and negative regulator PTP & epsilon;C in the DTI-induced STATs inhibition was also demonstrated. Overall, triazolyl-indolo-quinoxaline compounds like DTI show promise as inhibitors of the STAT3/STAT5 pathway in gastric cancer cells.

DRUG DEVELOPMENT RESEARCH (2023)

Review Chemistry, Medicinal

Modulation of carcinogenesis with selected GRAS nutraceuticals via Keap1-Nrf2 signaling pathway

Bhagyalakshmi Nair, Jayaprakash K. Adithya, Gopika Chandrababu, P. K. Lakshmi, Joel Joy Koshy, Sreedharan Vilasini Manoj, D. B. Ambiliraj, Balachandran S. Vinod, Gautam Sethi, Lekshmi R. Nath

Summary: Keap1-Nrf2 is a crucial signaling cascade for promoting or preventing carcinogenesis. Nutraceuticals, as dietary agents with health benefits, show great potential as chemoprevention agents for cancer. This review systematically analyzes the role of 12 different nutraceuticals in modulating the Nrf2/Keap1 signaling mechanism. Although there is considerable preclinical evidence, further high-quality research is needed to validate the potential role of these nutraceuticals in Keap1-Nrf2 modulation.

PHYTOTHERAPY RESEARCH (2023)

Article Oncology

Autophagy machinery in glioblastoma: The prospect of cell death crosstalk and drug resistance with bioinformatics analysis

Yi Qin, Shengjun Xiong, Jun Ren, Gautam Sethi

Summary: Autophagy plays an important regulatory role in glioblastoma, and its dysregulation can lead to drug resistance and radioresistance. It also affects stem cell characteristics, overall growth, and metastasis. Therefore, autophagy is a promising target for glioblastoma therapy.

CANCER LETTERS (2024)

Article Food Science & Technology

Nanoformulations of curcumin: An alliance for effective cancer therapeutics

Mangala Hegde, Aviral Kumar, Sosmitha Girisa, Babu Santha Aswani, Ravichandran Vishwa, Gautam Sethi, Ajaikumar B. Kunnumakkara

Summary: Cancer is a complex disease with diverse characteristics and treatment responses. Overcoming the recurrence and resistance to therapy, as well as minimizing side effects, is crucial for improving the quality of life in cancer patients. This review explores the potential benefits of nanocurcumin, a nanotechnology-based formulation of the natural compound curcumin, in cancer treatment. Various types of curcumin nanoformulations are discussed, along with their anticancer activities and cellular mechanisms. The review also highlights the potential of nanocurcumin as a preventive or adjuvant therapy with conventional drugs.

FOOD BIOSCIENCE (2023)

Article Oncology

Telomerase and hallmarks of cancer: An intricate interplay governing cancer cell evolution

Naveen Kumar, Gautam Sethi

Summary: Transformed cells acquire specific characteristics to become malignant. Telomerase, an enzyme complex, plays a significant role in maintaining telomere length. Its main component, TERT, interacts with various signaling molecules and promotes cancer hallmarks such as cell death resistance, sustained proliferation, angiogenesis activation, and metastasis. Understanding the role of telomerase in promoting cancer hallmarks is crucial for understanding the mechanism of cancer development and progression.

CANCER LETTERS (2023)

Review Chemistry, Multidisciplinary

Metal nanoparticles in cancer: from synthesis and metabolism to cellular interactions

Hardeep Singh Tuli, Ruchira Joshi, Ginpreet Kaur, Vivek Kumar Garg, Katrin Sak, Mehmet Varol, Jagjit Kaur, Sulaiman Ali Alharbi, Tahani Awad Alahmadi, Diwakar Aggarwal, Kuldeep Dhama, Vivek Sheel Jaswal, Sonam Mittal, Gautam Sethi

Summary: Nanotechnology has led to the development of new materials (metal nanoparticles) that have specific applications in healthcare, particularly in the diagnosis and treatment of cancer. Metal nanoparticles can modulate molecular expression in the tumor microenvironment and have anti-cancer effects by inducing apoptosis and cell cycle arrest. They can also inhibit tumor angiogenesis, metastasis, and inflammation, thus preventing cancer proliferation.

JOURNAL OF NANOSTRUCTURE IN CHEMISTRY (2023)

暂无数据